Qube Research & Technologies (QRT)
RCEL icon

Qube Research & Technologies (QRT)’s Avita Medical RCEL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-56,039
Closed -$783K – 2896
2023
Q1 		$783K Buy
56,039
+33,474
+148% +$356K ﹤0.01% 1388
2022
Q4 		$149K Buy
22,565
+4,461
+25% +$26.7K ﹤0.01% 1901
2022
Q3 		$95K Sell
18,104
-3,949
-18% -$24.4K ﹤0.01% 1985
2022
Q2 		$105K Buy
+22,053
New +$136K ﹤0.01% 1937
2021
Q2 		– Sell
-22,796
Closed -$452K – 2711
2021
Q1 		$452K Sell
22,796
-39,775
-64% -$925K 0.01% 1235
2020
Q4 		$1.16M Buy
+62,571
New +$1.37M 0.02% 828
2020
Q1 		– Sell
-3,331
Closed -$152K – 1561
2019
Q4 		$152K Buy
+3,331
New +$138K ﹤0.01% 1428

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Qube Research & Technologies (QRT)'s RCEL Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Avita Medical (RCEL) in Q2 2023, closing a stake of 56,039 shares — an estimated $783K sold.

Qube Research & Technologies (QRT) first reported a position in RCEL in Q4 2019 and held it in 7 quarters. The position peaked at $1.16M in Q4 2020. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Avita Medical position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 56,039 Avita Medical shares in Q2 2023, an estimated $783K.
  • Qube Research & Technologies (QRT) first reported a position in Avita Medical in Q4 2019 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s Avita Medical position peaked at $1.16M in Q4 2020.
  • 80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.